Alexander Sherry, Radiation Oncologist at MD Anderson Cancer Center, posted on his Twitter:
“P values have no place in the Table 1 of oncology RCTs. Why is this a problem, and how often do phase III RCTs contain the “Table 1 Fallacy”? Check out our newest study on clinical trial methodology published in the European Journal of Cancer. ”


Source: Alexander Sherry/Twitter